We are live on ! Find out more

885 hedge funds and large institutions have $21.1B invested in ResMed in 2025 Q1 according to their latest regulatory filings, with 107 funds opening new positions, 350 increasing their positions, 291 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 107 | Existing positions closed: 82

20% more repeat investments, than reductions

Existing positions increased: 350 | Existing positions reduced: 291

2.56% more ownership

Funds ownership: 61.7%64.26% (+2.6%)

2% more funds holding

Funds holding: 871885 (+14)

2% more capital invested

Capital invested by funds: $20.7B → $21.1B (+$402M)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

65% less call options, than puts

Call options by funds: $118M | Put options by funds: $340M

Holders
885
Holders Change
+14
Holders Change %
+1.61%
% of All Funds
11.87%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
107
Increased
350
Reduced
291
Closed
82
Calls
$118M
Puts
$340M
Net Calls
-$222M
Net Calls Change
+$108M

RMD Hedge Fund Activity: Q1 2025 in Review

885 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q1 2025, worth a combined $21.1B — up 1.9% from $20.7B a quarter earlier.

Buyers outnumbered sellers: 107 funds opened new RMD positions and 82 closed out — a net gain of 25 holders — while 350 added to existing stakes and 291 trimmed.

The largest buyer was Marshall Wace, adding an estimated $128M. The largest seller was Zurich Insurance Group, cutting an estimated $76.8M.

  • 885 institutional investors held ResMed (RMD) as of Q1 2025, up from 871 in Q4 2024.
  • Funds reported $21.1B of ResMed stock for Q1 2025, up 1.9% quarter-over-quarter.
  • 107 funds opened new ResMed positions in Q1 2025 and 82 closed out, a net change of +25 holders.
  • The largest ResMed buyer in Q1 2025 was Marshall Wace, an estimated $128M added.
  • The largest ResMed seller in Q1 2025 was Zurich Insurance Group, an estimated $76.8M sold.

Based on aggregated 13F filings for Q1 2025.